Balyasny Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,468	Closed	-$197K	–	1700
2018 Q3	$197K	Buy	+31,468	New	+$197K	﹤0.01%	1364
2016 Q3	–	Sell	-24,437	Closed	-$103K	–	1204
2016 Q2	$103K	Buy	24,437 +2,706	+12%	+$11.4K	﹤0.01%	925
2016 Q1	$95K	Buy	+21,731	New	+$95K	﹤0.01%	1001